Here at Artron, we are devoted to continuously upgrading our rapid diagnostic products according to the needs of the market. We offer a wide range of products from valuable medical diagnostic technology to innovative rapid tests that detect genetically modified organisms.
Artron Laboratories Inc. researches, develops, manufactures, and markets high quality rapid diagnostic test kits in a variety of formats to meet the needs of our clients.
We are committed to providing excellent service and high quality products at competitive prices, making our lateral flow test kits accessible around the world.
To meet challenges inherent in today's competitive biotechnology environment, Artron is working towards expanding from a sole R&D company to a well-rounded corporate entity that excels in both the science and business aspects of the market.
Artron operates in a 16,000 sq. ft. facility and is equipped with state-of-the-art R&D equipment for working in the fields of Molecular Biology, Monoclonal Antibody Development, Protein Purification and Rapid Test Kit Development. Our R&D team pride themselves on responsiveness, innovation, and the ability to manufacture large-scale production. We possess the advanced technology required for the development and manufacture of novel RDT products.